Lipoid pneumonia primary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{lipoid pneumonia}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no available vacci..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{lipoid pneumonia}} | {{lipoid pneumonia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{RG}} | ||
==Overview== | ==Overview== | ||
Lipoid pneumonia can be prevented by cessation of underlying cause like E-cigarette smoking or lipid based medications.it is also preventable by preventing aspiration pneumonia. effective measures for the primary prevention of aspiration pneumonia include [[Diet (nutrition)|dietary]] habit changes, maintaining [[oral hygiene]], postural maneuvers, and [[Medication|medications]] such as [[H2 antagonist|H2 antagonists]], [[metoclopramide]], [[mosapride]], [[amantadine]], or [[cilostazol]]. | |||
[ | |||
==Primary Prevention== | ==Primary Prevention== | ||
*Effective measures for the primary prevention of lipoid pneumonia include:<ref name="pmid18179994">{{cite journal |vauthors=El Solh AA, Saliba R |title=Pharmacologic prevention of aspiration pneumonia: a systematic review |journal=Am J Geriatr Pharmacother |volume=5 |issue=4 |pages=352–62 |date=December 2007 |pmid=18179994 |doi=10.1016/j.amjopharm.2007.12.005 |url=}}</ref><ref name="pmid18261707">{{cite journal |vauthors=Sarin J, Balasubramaniam R, Corcoran AM, Laudenbach JM, Stoopler ET |title=Reducing the risk of aspiration pneumonia among elderly patients in long-term care facilities through oral health interventions |journal=J Am Med Dir Assoc |volume=9 |issue=2 |pages=128–35 |date=February 2008 |pmid=18261707 |doi=10.1016/j.jamda.2007.10.003 |url=}}</ref><ref name="pmid23238778">{{cite journal |vauthors=Takatori K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Yoneda S, Adachi K, Amano Y, Kinoshita Y |title=Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding |journal=J. Gastroenterol. |volume=48 |issue=10 |pages=1105–10 |date=October 2013 |pmid=23238778 |doi=10.1007/s00535-012-0725-6 |url=}}</ref> | |||
**lessening lipid base prescriptions. | |||
**quieting E-cigarette and vaping. | |||
**Bed positioning | |||
**[[Diet (nutrition)|Dietary]] habit changes such as: | |||
***Eating small meals at a slow pace and consistent | |||
***Elevated position at least 1 to 2 hours after meals | |||
***Elemental diets in bedridden [[PEG gastroscopy|PEG]] patients | |||
**Good [[oral hygiene]] such as: | |||
*[ | ***Professional cleaning of the oral cavity weekly | ||
*[ | ***Tooth brushing after each meal | ||
*[ | ***Cleaning [[dentures]] daily | ||
***Gargling of [[disinfectant]] solution | |||
**Postural maneuvers and [[swallowing]] training to improve [[swallowing]] difficulties | |||
**Checking [[Feeding tube|feeding tubes]] regularly to prevent displacement | |||
[ | **Administrating postpyloric [[feeding]] than [[Feeding tube|gastric feeding]] | ||
*[ | **[[Medication|Medications]] such as: | ||
*[ | ***[[H2 antagonist|Histamine-2 receptor antagonists]] | ||
*[ | ***[[Metoclopramide]] | ||
***[[Mosapride]] | |||
***[[Amantadine]] | |||
***[[Cilostazol]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 02:50, 23 October 2019
|
Lipoid pneumonia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lipoid pneumonia primary prevention On the Web |
|
American Roentgen Ray Society Images of Lipoid pneumonia primary prevention |
|
Risk calculators and risk factors for Lipoid pneumonia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Lipoid pneumonia can be prevented by cessation of underlying cause like E-cigarette smoking or lipid based medications.it is also preventable by preventing aspiration pneumonia. effective measures for the primary prevention of aspiration pneumonia include dietary habit changes, maintaining oral hygiene, postural maneuvers, and medications such as H2 antagonists, metoclopramide, mosapride, amantadine, or cilostazol.
Primary Prevention
- Effective measures for the primary prevention of lipoid pneumonia include:[1][2][3]
- lessening lipid base prescriptions.
- quieting E-cigarette and vaping.
- Bed positioning
- Dietary habit changes such as:
- Eating small meals at a slow pace and consistent
- Elevated position at least 1 to 2 hours after meals
- Elemental diets in bedridden PEG patients
- Good oral hygiene such as:
- Professional cleaning of the oral cavity weekly
- Tooth brushing after each meal
- Cleaning dentures daily
- Gargling of disinfectant solution
- Postural maneuvers and swallowing training to improve swallowing difficulties
- Checking feeding tubes regularly to prevent displacement
- Administrating postpyloric feeding than gastric feeding
- Medications such as:
References
- ↑ El Solh AA, Saliba R (December 2007). "Pharmacologic prevention of aspiration pneumonia: a systematic review". Am J Geriatr Pharmacother. 5 (4): 352–62. doi:10.1016/j.amjopharm.2007.12.005. PMID 18179994.
- ↑ Sarin J, Balasubramaniam R, Corcoran AM, Laudenbach JM, Stoopler ET (February 2008). "Reducing the risk of aspiration pneumonia among elderly patients in long-term care facilities through oral health interventions". J Am Med Dir Assoc. 9 (2): 128–35. doi:10.1016/j.jamda.2007.10.003. PMID 18261707.
- ↑ Takatori K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Yoneda S, Adachi K, Amano Y, Kinoshita Y (October 2013). "Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding". J. Gastroenterol. 48 (10): 1105–10. doi:10.1007/s00535-012-0725-6. PMID 23238778.